APA

Zhang X., Shieh C., Chapman M. L., Matulenko M. A., Hakeem A. H., Atkinson R. N., Kort M. E., Marron B. E., Joshi S., Honore P., Faltynek C. R., Krafte D. S. & Jarvis M. F. (20101014). A-887826 is a structurally novel, potent and voltage-dependent Na(v)1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in rats. : Neuropharmacology.

Chicago

Zhang Xu-Feng, Shieh Char-Chang, Chapman Mark L, Matulenko Mark A, Hakeem Ahmed H, Atkinson Robert N, Kort Michael E, Marron Brian E, Joshi Shailen, Honore Prisca, Faltynek Connie R, Krafte Douglas S and Jarvis Michael F. 20101014. A-887826 is a structurally novel, potent and voltage-dependent Na(v)1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in rats. : Neuropharmacology.

Harvard

Zhang X., Shieh C., Chapman M. L., Matulenko M. A., Hakeem A. H., Atkinson R. N., Kort M. E., Marron B. E., Joshi S., Honore P., Faltynek C. R., Krafte D. S. and Jarvis M. F. (20101014). A-887826 is a structurally novel, potent and voltage-dependent Na(v)1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in rats. : Neuropharmacology.

MLA

Zhang Xu-Feng, Shieh Char-Chang, Chapman Mark L, Matulenko Mark A, Hakeem Ahmed H, Atkinson Robert N, Kort Michael E, Marron Brian E, Joshi Shailen, Honore Prisca, Faltynek Connie R, Krafte Douglas S and Jarvis Michael F. A-887826 is a structurally novel, potent and voltage-dependent Na(v)1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in rats. : Neuropharmacology. 20101014.